Bleomycin (BLM) is a chemotherapeutic agent which is associated with Idiopathic
pulmonary fibrosis (IPF) due to its chronic administration. Hesperidin, a bioflavonoid has …

Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There
are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven …

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause and limited to the lungs. Schisandrae …

Abstract Background Yangqing Chenfei formula (YCF) is a traditional Chinese medicine
formula for early-stage silicosis. However, the therapeutic mechanism is unclear. The …

Pulmonary fibrosis (PF) is a chronic pulmonary interstitial disease, and its pathological
process is closely related to fibroblast–myofibroblast differentiation. Danshensu (DSS) has …

OBJECTIVE: The aim of this study was to investigate the effect of resveratrol on the
idiopathic bleomycin (BLM)-induced pulmonary fibrosis, which is increasingly recognized as …

Abstract Ethnopharmacological relevance Fu-Zheng-Tong-Luo (FZTL) formula is a Chinese
herbal prescription which is used to treat idiopathic pulmonary fibrosis (IPF). We previously …

Bleomycin (BLM), a frequently employed chemotherapeutic agent, exhibits restricted clinical
utility owing to its pulmonary toxicity. Meanwhile, baicalin (BA)—an active ingredient …

Abstract Background Jinshui Huanxian formula (JHF) ameliorates idiopathic pulmonary
fibrosis patients. Active compounds, including icariin, isoliquiritigenin, nobiletin, peimine …

Idiopathic pulmonary fibrosis (IPF) is a devastating and common chronic lung disease
pathologically characterized by loss of epithelial cells and activation of fibroblasts and …